Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Premature Birth × Metformin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 134 Breast Neoplasms 36 Prostatic Neoplasms 30 Insulin Resistance 28 Obesity 18 Pancreatic Neoplasms 14 Neoplasms 13 Endometrial Neoplasms 13 Infertility 12 Colorectal Neoplasms 12 Carcinoma, Non-Small-Cell Lung 12 Anovulation 10 Lung Neoplasms 9 Neoplasm Metastasis 8 Glioblastoma 8 Metabolic Syndrome 7 Hyperandrogenism 7 Diabetes Mellitus 7 Squamous Cell Carcinoma of Head and Neck 6 Melanoma 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma, Large B-Cell, Diffuse 5 Brain Neoplasms 5 Adenocarcinoma 5 Weight Loss 4 Rectal Neoplasms 4 Ovarian Neoplasms 4 Mouth Neoplasms 4 Head and Neck Neoplasms 4 Diabetes Mellitus, Type 2 4

Interventions

Utrogestan 1 Timolol 1 Tablets 1 Population Groups 1 Metformin 1 Inositol 1 Cholecalciferol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00159536 2019-02-15

PregMet

Norwegian University of Science and Technology

Phase 3 Completed

Diabetes Mellitus, Polycystic Ovary Syndrome, Pre-Eclampsia, Premature Birth

Data powered by HemOnc (CC BY 4.0) Colophon ⚡